This was first robustly demonstrated through the identification of four main intrinsic breast cancer subtypes with important prognostic implications, now evaluated using the PAM50 expression microarray: two luminal epithelial groups (A and B); a HER2 over-expressing group; and a basal-like group that is largely TNBC [12, 13]. This evidence concerns the gene ERBB2 and breast carcinoma.